Covaxin Can Work Against Mutated Coronavirus, Says Bharat Biotech Chairman

Bharat Biotech MD Krishna Ella also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, which is now undergoing phase 3 trials.

Similar Articles

Most Popular